Event preview: BioPharm America 2018
More than 700 global life science executives from sectors including pharma, established biotech, startups and investors will converge in Boston on September 5 and 6 for BioPharm America, where they will be seeking strategic opportunities for new deals to advance drug development partnerships. As part of Biotech Week Boston, the event is produced by EBD Group and will take place at the Hynes Convention Center in Boston.
The event provides opportunities for biotech startups to meet industry experts and network with investors including one-to-one partnering, presentation opportunities, and startup pitch competition.
“Each year, BioPharm America draws industry leaders from around the world to this unique partnering event that provides a nexus for discovery and realisation,” says Anna Chrisman, group managing director, EBD Group.
“The event plays a vital role in connecting emerging biotech with companies that seek to work with them, facilitating partnerships that drive growth and innovation.”
Attendees will hear from experts during the new Xcelerate keynote series, including biotech pioneer Robert Langer from MIT; Amy Shulman, CEO at Lyndra and partner at Polaris Partners; US Surgeon General Jerome Adams; and Elizabeth Nabel, president at Brigham Health.
